Can we cure metastatic EGFR-mutated lung cancer today?

Transl Cancer Res. 2023 Feb 28;12(2):209-212. doi: 10.21037/tcr-22-2926. Epub 2023 Feb 1.

Author

Petros Christopoulos^{1

2}

Affiliations

¹ Department of Medical Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.
² Translational Lung Research Center at Heidelberg University Hospital, Member of the German Center for Lung Research (DZL), Heidelberg, Germany.

No abstract available

Keywords: Epidermal growth factor receptor lung cancer (EGFR lung cancer); biomarkers; long-term survival; tyrosine kinase inhibitors (TKI).

Publication types

Editorial
Comment